Clinical trial

Acetyl-L-Carnitine in Type 2 Diabetes

NCT00984750

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-04-01

PhasePHASE3

Study timeline

Study start (unknown)2008-04-01Date precision: month

Registry last updated2013-02-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Type 2unresolved

Hypertensionunresolved

Interventions

acetyl-L-carnitine/statin (simvastatin)DRUG

placeboDRUG

Sponsors & collaborators

Mario Negri Institute for Pharmacological Researchlead sponsor

Leadiant Biosciences, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00984750 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.